2025-11-04T16:04:24-06:00 2024-12-31 450250958 Eide Bailly LLP 877 W Main St Ste 800 Boise ID 837025858 990 2024-01-01 923319884 Nevada Coalition for Psychedelic Medicines NEVA 7752507973 1350 Feather Way Reno NV 89509 Catherine Cotter Executive Director & Treasurer 7752507973 2025-11-03 1 1 Kimberly C Nelson CPA P01887713 2083447150 2025-11-03 2024 2025-03-06 01:10:19Z Catherine Cotter 1350 Feather Way Reno NV 89509 296353 0 X nevadacpm.org X 2023 NV To educate and advocate for psychedelic-assisted therapy to save lives and improve mental health 6 4 0 20 0 0 24751 296243 0 106 0 4 0 0 24751 296353 4271 0 0 0 0 127478 0 0 36872 16939 64330 21210 191808 3541 104545 3581 113897 0 5771 3581 108126 X To champion the legalization of psychedelic-assisted therapy and the reduction of penalties. Through education, collaboration, cultural change, and policy reform, we are fighting to save lives and revolutionize mental health. 0 0 74032 Legislative Advocacy & Policy Reform:NCPM advocates for legislation and policy reforms that expand access to psychedelic-assisted therapies, particularly for veterans, first responders, and others with treatment-resistant conditions. In 2024, we engaged directly with Nevada legislators, testified at hearings, coordinated with national advocacy partners, and organized public awareness efforts to support safe and regulated access to psychedelic therapies.(Continued on Schedule O)Key accomplishments include:- Meeting with Nevada state senators and assembly members to advance psychedelic therapy legislation.- Providing policy recommendations in collaboration with national partners including veteran and law enforcement non-profits. - Building bipartisan support and educating policymakers on the therapeutic potential and public health benefits of psychedelic-assisted therapy.In 2024, NCPM leadership also served on the Nevada Psychedelic Medicines Working Group, established under SB242 (passed in 2023 with NCPM's support). Through this role and sustained interim advocacy, NCPM helped shape key policy recommendations that led to the introduction of two major bills in 2025: SJR10, a resolution urging Congress to reschedule certain psychedelics, allocate funding for research, and expand access to therapy, and AB378, a pilot program providing regulated access to psilocybin therapy for veterans and former first responders. SJR10 passed with bipartisan support, with 27 legislators signing on as sponsors or co-sponsors; AB378 was similarly backed by 24 bipartisan supporters. Throughout the year, NCPM remained committed to its mission to advance safe, equitable, and science-informed psychedelic policy in Nevada. 62949 106 Public Education and Community Engagement:NCPM advances public understanding about the therapeutic potential of psychedelic medicines through educational outreach and community engagement efforts aimed at shifting public perception, informing policy, and empowering stakeholders. In 2024, we hosted virtual summits and webinars addressing emerging clinical research and state and federal policy developments, published regular newsletters, and distributed educational content on safe, equitable access to psychedelic therapies. These initiatives aimed to inform both the public and policymakers, supporting cultural change and legislative momentum.(Continued on Schedule O)Accomplishments may include:- Produced and distributed digital newsletters highlighting local and national psychedelic policy developments.- Hosted online educational events, including webinars and virtual summits, to inform the public about access models, research, and regulation.- Maintained active engagement across digital platforms, reaching approximately 2,300 followers across email and combined social platforms.- Provided informational resources to policymakers and the public in support of safe, regulated psychedelic-assisted therapies. 136981 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1 1 0 0 0 1 1 0 0 0 X 6 4 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 0 0 0 0 0 X Catherine Cotter 7752507973 1350 Feather Way Reno NV 89509 Eric Anderson Secretary 1.00 0.00 X X 0 0 0 Catherine Cotter Executive Director/Treasurer 40.00 0.00 X X 59000 0 0 Jonathan Dalton CEO/President 40.00 0.00 X X 77000 0 0 Greg Rea Director (Until Jan '24) 1.00 0.00 X 0 0 0 Tory Clark Director (Until Jan '24) 1.00 0.00 X 0 0 0 Justin Van Pelt Director (Until Jan '24) 1.00 0.00 X 0 0 0 Bryan Lang Director 1.00 0.00 X 0 0 0 Matt Peek Director (Until Apr '24) 1.00 0.00 X 0 0 0 Barry Cole Director 1.00 0.00 X 0 0 0 Dr Sam Zand Director 1.00 0.00 X 0 0 0 136000 0 0 0 0 0 1 0 296243 296243 106 106 106 4 4 296353 106 0 4 113000 79100 11300 22600 4750 1900 2850 9728 6701 936 2091 1803 1803 24233 24233 13500 5400 8100 599 559 40 1105 10 1095 2128 249 1879 13993 12641 241 1111 6639 6188 331 120 Taxes and Licenses 330 330 191808 136981 17955 36872 3180 18543 401 95304 0 50 3581 113897 5771 0 5771 X 0 0 0 0 0 104545 3581 108126 3581 113897 104545 0 X 0 0 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 0 Jonathan Dalton CEO/President 77000 0 0 0 0 0 0 0 0 0 77000 0 0 0 Catherine Cotter Executive Director/Treasurer 59000 0 0 0 0 0 0 0 0 0 59000 0 0 0 Part I, Line 3 The organization does not establish the compensation of the CEO/President nor the Executive Director/Treasurer. Compensation is determined by Sierra Psychedelic Society (SPS), an unrelated organization, and the organization relied on SPS to establish compensation. Schedule J, Part II reports total compensation paid to both officers. The organization reimbursed SPS for officer compensation totalling $113,000 as reported on Form 990, Part IX, Line 5. Form 990, Part VI, Section A, line 8b No committees are able to act on behalf of the board. Form 990, Part VI, Section B, line 11b The draft Form 990 is prepared by the Coalition's CPA or accounting team and reviewed by the Executive Director and Treasurer for accuracy and completeness. Once the draft is finalized, a full copy is distributed to all board members via email for review. Board members are given an opportunity to ask questions or request clarifications before Form 990 is officially filed with the IRS. Form 990, Part VI, Section B, line 12c All members of the board, officers, and members of committees with board delegated authority are covered by the written conflict of interest policy and are required to disclose annually any interests that could give rise to conflict. Potential conflicts of interest are reviewed by the Board and if anyone is determined to have a conflict of interest, they will be removed from all meetings, discussions, and will not be allowed to vote in those specified areas of conflict. Form 990, Part VI, Section B, line 15 The Nevada Coalition for Psychedelic Medicines does not employ staff directly. Compensation for the CEO/President and Executive Director/Treasurer is paid by Sierra Psychedelic Society, an unrelated organization, with a portion reimbursed for services provided to the Coalition. To ensure reasonable compensation, the Coalition plans to implement a formal process that includes board review and approval, documentation of deliberations, and reliance on comparability data from nonprofit salary surveys or similarly sized organizations to support compensation decisions. Form 990, Part VI, Section C, line 19 The Nevada Coalition for Psychedelic Medicines' governing documents, conflict of interest policy and financial statements are available for public inspection upon request. Form 990, Part VI, Section A, Line 4: During the 2024 tax year, the Nevada Coalition for Psychedelic Medicines' bylaws included a member structure; however, the organization has never implemented or maintained formal membership and is governed solely by its Board of Directors. In 2025, the bylaws were amended to remove all language related to membership.